Helen M. Thackray, SVP Clinical Development, CMO at GLYCOMIMETICS INC (GLYC), sold 2,000 shares at $15.01 ($30K) on 2017-12-08, disclosed to the SEC on 2017-12-12.
Open-market sale of $30k GLYC by SVP Clinical Development, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2022-12-19 | $34K | — | Filing → |
| BCRX | SELL | 2022-04-04 | $123K | — | Filing → |
| GLYC | SELL | 2017-09-18 | $26K | — | Filing → |